What are the pharmacokinetics of post-attachment inhibitors in antiretroviral therapy of HIV infection?

Updated: Apr 18, 2019
  • Author: R Chris Rathbun, PharmD, BCPS (AQ-ID), AAHIVP; Chief Editor: John Bartlett, MD  more...
  • Print
Answer

Answer

Ibalizumab maintenance therapy requires every 2 week IV infusions. The elimination half-life is approximately 3 days. It has not been shown to have any interactions. Dose modifications of ibalizumab are not required when administered with any other ARTs or any other drugs. [102, 103]


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!